Skip to content

La Fundación de Trastornos Hemorrágicos Lone Star se complace en anunciar el Fondo de Becas Académicas Conmemorativa Matthew Thomas

Para servir a la comunidad de trastornos hemorrágicos del sur de Texas, Lone Star BDF otorgará hasta cuatro becas académicas de $2,500 para el año escolar 2023-2024.

Para poder ser eligible para la beca académica, los estudiantes deben estar directamente afectados por un trastorno hemorrágico hereditario, o ser familiares directos de alguien que padezca un trastorno hemorrágico (padre/madre/tutor/hermano/hijo de) y estar cursando estudios en una universidad, instituto o colegio semisuperior acreditados. No es necesario que sean estudiantes de primer curso. Esta beca está abierta a cualquier persona que esté cursando estudios universitarios.

Junto con una solicitud de beca completa, los solicitantes calificados deben proporcionar documentación de inscripción postsecundaria, expedientes académicos de la escuela secundaria/universidad, cartas de recomendación y ensayo personal. Una persona solo puede recibir una beca una vez.

Descargar una versión PDF de la solicitud

Lista de verificación de la Beca Académica Conmemorativa Matthew Thomas

Presentar la solicitud completa y los documentos requeridos en nuestro sitio web www.lonestarbleedingdisorders.org en la pestaña Recursos, antes del 30 de abril de 2023.

También puede enviar la solicitud y los documentos impresos, y debe llevar matasellos postal fechado el 30 de abril de 2023 a:

Lone Star Bleeding Disorders Foundation

ATTN: Scholarship Committee

5600 Northwest Central Suite 140

Houston, TX 77092

O envíe correo electrónico a Heidi Hensley

Asegúrese de incluir:
    • Solicitud completa
    • Expediente académico de escuela secundaria o universidad
    • Documentación de inscripción en estudios postsecundarios
    • Ensayo personal
    • Dos cartas de recomendación

News from HFA

  • Leading Advocacy Organizations Celebrate Federal Rule Strengthening Protections Against Disability Discrimination 

    The Bleeding Disorders Substance Use and Mental Health Access Coalition (BD SUMHAC), National Bleeding Disorder Foundation (NBDF) and Hemophilia Federation of America (HFA) are pleased to share that after advocacy from the bleeding disorders community, the U.S. Department of Health and Human Services (HHS), through its Office for Civil Rights (OCR), finalized a new rule The post Leading Advocacy Organizations Celebrate Federal Rule Strengthening Protections Against Disability Discrimination  appeared first on Hemophilia Federation of America.

  • Advocacy News: April 2024

    Word from Washington After one year, Medicaid coverage losses during “unwinding” continue to surpass worst fears According to the latest KFF Medicaid Unwinding Enrollment Tracker, more than 21 millionAmericans have lost Medicaid coverage during the first year after states were allowed to resume eligibility verifications following the COVID-19 public health emergency. There remains wide variation The post Advocacy News: April 2024 appeared first on Hemophilia Federation of America.

  • May is Hepatitis Awareness Month

    In 2001, the Centers for Disease Control and Prevention designated the month of May as Hepatitis Awareness Month to bring awareness and attention to those living with viral hepatitis. In the 1980s and ’90s, thousands of people with hemophilia contracted HIV and hepatitis C (HCV) from the contaminated blood supply transmitted by clotting factor products. The post May is Hepatitis Awareness Month appeared first on Hemophilia Federation of America.

  • FDA Approves One-Time Gene Therapy for Adults with Hemophilia B

    From Pfizer: Pfizer Inc. announced that the US Food and Drug Administration has approved BEQVEZ™ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B who currently use factor IX (FIX) prophylaxis therapy, or have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes, and do not have neutralizing The post FDA Approves One-Time Gene Therapy for Adults with Hemophilia B appeared first on Hemophilia Federation of America.

  • Advocacy News: March 2024

    Word From Washington Federal Agencies Supreme Court Congress State of the States Oregon becomes first state in 2024 to pass protections against copay accumulator adjusters. Oregon Governor Tina Kotek (D) signed legislation unanimously passed by the House and Senate that protects consumers in state-regulated health plans from harmful and discriminatory copay accumulator adjuster programs (CAAPs). The post Advocacy News: March 2024 appeared first on Hemophilia Federation of America.